��ɫ��

��ɫ��

Events

Resources For

Abstract Details

Title Clinical Deterioration and Increased Axonal Dysfunction in Charcot-Marie-Tooth Type 1A: A 5-Year Natural History Study

Topic Peripheral Nerve

Presentation(s) (-)

Poster/Presentation
Number 008

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Camiel C. Verhamme, MD	No disclosure on file
Michael Boffa, MD	Dr. Boffa has received personal compensation for serving as an employee of Jazz Pharmaceuticals. An immediate family member of Dr. Boffa has received personal compensation for serving as an employee of Biogen. Dr. Boffa has stock in Jazz Pharmaceuticals. An immediate family member of Dr. Boffa has stock in Biogen.
Ivo N. Van Schaik, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
Justin P. Martello, MD, FAAN (ChristianaCare Neurology Specialists)	Dr. Martello has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Martello has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Martello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Martello has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus. Dr. Martello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Martello has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia.
Marianne De Visser, MD, PhD (Academic Med Center)	Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. De Visser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca.